NuScale Power: Regulatory Wins Clash With Financial Performance

NuScale Power shares extended their positive momentum into a third consecutive session on Friday, closing at $40.12 with a 1.54 percent gain. This upward trend persists despite mounting questions about the company’s ability to deliver on its ambitious commercial objectives.

Regulatory Milestones Strengthen Market Position

The company solidified its pioneering status in the competitive small modular reactor sector with a significant regulatory achievement. In May 2025, NuScale secured its second Standard Design Approval from the U.S. Nuclear Regulatory Commission for its 77-MWe SMR design. This endorsement arrived ahead of schedule, reinforcing the company’s technological leadership.

However, this regulatory success contrasts sharply with recent financial results. NuScale’s second-quarter 2025 earnings fell substantially short of projections. The company reported a per-share loss of $0.13 with revenue reaching only $8.1 million. Market experts had anticipated a narrower loss of $0.11 per share alongside higher revenue of $11.89 million.

Major Contracts: The Path to Profitability?

CEO John Hopkins and his leadership team maintain their commitment to securing “binding agreements” with “two or three major U.S. clients” before 2025 concludes. Several substantial initiatives are currently advancing:

Should investors sell immediately? Or is it worth buying Nuscale Power?

• Collaboration on the ENTRA1 energy arrangement with the Tennessee Valley Authority targeting up to 6 gigawatts of SMR capacity
• A tripartite $32.3 million agreement involving the U.S. Department of Energy and CFPP LLC for reactor components
• Development progress on a potential power plant project in Romania

Market sentiment remains divided regarding these prospects. Bank of America analysts cautioned in late September 2025 about what they termed “unrealistic expectations” surrounding SMR equities. Adding to the uncertainty, major stakeholder Fluor divested approximately 4.1 million common shares valued around $200 million between September 19-23, 2025.

Valuation Versus Operational Reality

With an $11 billion market capitalization, NuScale continues to generate modest revenue primarily through licensing and engineering services. This significant gap between market valuation and current financial performance highlights the speculative nature of the investment.

The coming months will prove critical for the company’s trajectory. Will NuScale successfully finalize the major contracts it has promised by year-end, or will investor disappointment reverse the current positive trend? The company stands at a crossroads where regulatory achievements must soon translate into commercial success.